Skip to main content
. 2020 Jul 25;31:101180. doi: 10.1016/j.rmcr.2020.101180

Table 1.

Results of rapid immunochromatographic test for detecting SARS-CoV-2 antibody.

Case Onset (month year) Age, sex Underlying disease Coronavirus subtype Specimen in which virus was detected Laboratory results
Serum antibody
WBC,/mm3 Lym,/mm3 CRP, mg/dL D-dimer, μg/mL PCT, ng/mL IgG Day of illness sample obtained IgM Day of illness sample obtained
1 Feb 2017 71, F HT OC43 BALF 14,300 500 14.91 2.04 0.19 23 23
2 Oct 2015 49, M None 229E BALF 8900 1500 4.82 0.34 N.E 5 5
3 Jun 2016 65, F None 229E BALF 9200 2400 0.40 0.76 N.E + 31 + 31
4 Aug 2017 81, M HT 229E BALF 9600 1400 17.49 1.88 0.09 8 8
5 Oct 2017 76, M DM 229E BALF 4600 600 9.21 6.04 0.08 12 12
+ 95
6 Oct 2019 65, M HT, AF 229E Sputum 12,000 1500 9.57 0.39 0.04 + 6 6
7 Apr 2020 72, M Gout HKU1 Nasopharyngeal swab 8000 1300 5.70 3.15 0.06 16 16
+ 22 22
+ 23 23

M denotes male; F, female; DM, diabetes mellitus; HT, hypertension; AF, atrial fibrillation; BALF, bronchoalveolar lavage fluid; WBC, white blood cell; Lym, lymphocytes; CRP, C-reactive protein; PCT, procalcitonin; and N.E, not evaluated.